Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws?

被引:15
作者
Shimamoto, Hiroaki [1 ,2 ]
Grogan, Tristan R. [3 ]
Tsujimoto, Tomomi [1 ]
Kakimoto, Naoya [4 ]
Murakami, Shumei [1 ]
Elashoff, David [3 ]
Aghaloo, Tara L. [5 ]
Tetradis, Sotirios [2 ]
机构
[1] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Radiol, Suita, Osaka, Japan
[2] Univ Calif Los Angeles, Sch Dent, Sect Oral & Maxillofacial Radiol, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Stat Core, Los Angeles, CA 90095 USA
[4] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Radiol, Minami Ku, Hiroshima, Japan
[5] Univ Calif Los Angeles, Sch Dent, Sect Oral & Maxillofacial Surg, Los Angeles, CA 90024 USA
关键词
CBCT; stage; 0; ONJ; diagnostic thinking efficacy; management; prognosis; BISPHOSPHONATE-RELATED OSTEONECROSIS; BEAM COMPUTED-TOMOGRAPHY; IMAGING FINDINGS; ZOLEDRONIC ACID; BONE METASTASES; BEVACIZUMAB; CANCER; DENOSUMAB; SUNITINIB; VARIANT;
D O I
10.1259/dmfr.20170290
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives: To evaluate the impact of cone beam CT (CBCT) in the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaw (MRONJ). Methods: For 15 patients with suspected Stage 0 MRONJ, clinical photographs, a panoramic radiograph and selected CBCT sections were identified. 13 oral surgeons reviewed the material and answered 10 questions in two different sessions. First session included clinical photographs and panoramic radiographs, while second session also included CBCT images. Questions (Qs) referred to dental disease and bone abnormalities (Qs 1, 2 and 3), differential diagnosis (Qs 4 and 5), patient management (Qs 6 and 7) and prognosis (Qs 8 and 9). Q 10 queried indication (first session) and usefulness (second session) of CBCT images. Results: Qs 2, 3, 5, 7 and 9 scores increased between sessions, with statistical differences for Qs 2, 3, 5 and 7 (<0.05). Patients 2, 8 and 11 showed a significant increase in the average score of all Qs between sessions, while scores for patient 10 nearly reached statistical significance (p = 0.055). For Q 10, 57.4% of answers reported that CBCT was needed (first session) and was beneficial (second session). Conclusions: CBCT had a significant impact in differential diagnosis and management of patients with suspected Stage 0 MRONJ.
引用
收藏
页数:8
相关论文
共 41 条
  • [1] Stage 0 Osteonecrosis of the Jaw in a Patient on Denosumab
    Aghaloo, Tara L.
    Dry, Sarah M.
    Mallya, Sanjay
    Tetradis, Sotirios
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2014, 72 (04) : 702 - 716
  • [2] Imaging Findings in Bisphosphonate-Related Osteonecrosis of Jaws
    Arce, Kevin
    Assael, Leon A.
    Weissman, Jane L.
    Markiewicz, Michael K.
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (05) : 75 - 84
  • [3] Bisphosphonate-Related Osteonecrosis of the Jaw: Model and Diagnosis with Cone Beam Computerized Tomography
    Barragan-Adjemian, C.
    Lausten, L.
    Ang, D. B.
    Johnson, M.
    Katz, J.
    Bonewald, L. F.
    [J]. CELLS TISSUES ORGANS, 2009, 189 (1-4) : 284 - 288
  • [4] Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer
    Bianch, Silvio Diego
    Scoletta, Matteo
    Cassione, Francesca Bozzalla
    Migliaretti, Giuseppe
    Mozzati, Marco
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2007, 104 (02): : 249 - 258
  • [5] Current concepts in maxillofacial imaging
    Boeddinghaus, Rudolf
    Whyte, Andy
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2008, 66 (03) : 396 - 418
  • [6] Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain
    Diniz-Freitas, Marcio
    Lopez-Cedrun, Jose-Luis
    Fernandez-Sanroman, Jacinto
    Garcia-Garcia, Abel
    Fernandez-Feijoo, Javier
    Diz-Dios, Pedro
    [J]. MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2012, 17 (05): : E751 - E758
  • [7] Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients
    Dranitsaris, George
    Hatzimichael, Eleftheria
    [J]. SUPPORTIVE CARE IN CANCER, 2012, 20 (07) : 1353 - 1360
  • [8] Osteonecrosis of the jaw related to bevacizumab
    Estilo, Cherry L.
    Fornier, Monica
    Farooki, Azeez
    Carlson, Diane
    Bohle, George, III
    Huryn, Joseph M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) : 4037 - 4038
  • [9] Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series
    Fedele, Stefano
    Porter, Stephen R.
    D'Aiuto, Francesco
    Aljohani, Suad
    Vescovi, Paolo
    Manfredi, Maddalena
    Arduino, Paolo G.
    Broccoletti, Roberto
    Musciotto, Anna
    Di Fede, Olga
    Lazarovici, Tony S.
    Campisi, Giuseppina
    Yarom, Naom
    [J]. AMERICAN JOURNAL OF MEDICINE, 2010, 123 (11) : 1060 - 1064
  • [10] Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
    Fizazi, Karim
    Carducci, Michael
    Smith, Matthew
    Damiao, Ronaldo
    Brown, Janet
    Karsh, Lawrence
    Milecki, Piotr
    Shore, Neal
    Rader, Michael
    Wang, Huei
    Jiang, Qi
    Tadros, Sylvia
    Dansey, Roger
    Goessl, Carsten
    [J]. LANCET, 2011, 377 (9768) : 813 - 822